Correction to: Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1–84) in hypoparathyroidism
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsThyroid and Parathyroid Surgery
This is a correction to: Aliya A Khan, Lisa G Abbott, Intekhab Ahmed, Olulade Ayodele, Claudia Gagnon, Richard D Finkelman, Emese Mezosi, Lars Rejnmark, Istvan Takacs, Shaoming Yin, Steven W Ing, Open-label extension of a randomized trial investigating safety and efficacy of rhPTH(1–84) in hypoparathyroidism, JBMR Plus, Volume 8, Issue 3, March 2024, ziad010, https://doi.org/10.1093/jbmrpl/ziad010.
Affiliation information has been updated to reflect that Takeda Development Center Americas Inc. is located in Cambridge, MA, and that the tenth-listed author is affiliated with Takeda Pharmaceuticals USA, Inc. rather than Takeda Development Center Americas Inc.